Accumulation of Somatic Mutation in Mitochondrial DNA and Atherosclerosis in Diabetic Patients
Abstract
A bstract: A point mutation of mitochondrial DNA at nucleotide position 3243 A to G is responsible for the genetic cause of diabetes. Otherwise, this mutation is also reported to occur as a somatic mutation, possibility because of oxidative stress. Because diabetes may cause oxidative stress, we hypothesized that accumulation of the somatic A3243G mutation in mitochondrial DNA may be accelerated by diabetes. DNA was extracted from blood samples of 290 nondiabetic healthy subjects (aged 0‐60 years) and from 383 type 2 diabetic patients (aged 18‐80 years). Then, the extent of somatic A3243G mutation in total mitochondrial DNA was detected by real‐time polymerase chain reaction (PCR) using the TaqMan probe. The genotyping of ACE I/D or p22phox C242T was done by PCR or PCR‐restriction fragment length polymorphism. Although the level of the A3243G mutation was negligible in the newborn group, it increased in healthy subjects aged 20‐29 and 41‐60 years. In diabetic patients, the mutational rate increased along with age and the duration of diabetes. In the middle‐aged group (41‐60 years old), the A3243G mutation accumulates fourfold higher in the diabetic patients than in the healthy subjects. Moreover, multiple regression analysis revealed that the most critical factor associated with this mutation in diabetic patients was the duration of diabetes. Furthermore, the genotype of DD, DI‐CC (ACE‐p22phox) has the highest mutational rate and the thickest intima‐media thickness of the carotid artery. In conclusion, diabetes accelerates the accumulation of the somatic A3243G mutation in mitochondrial DNA, and this somatic mutation may be a marker for the duration of diabetes and atherosclerosis.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
mtDNA mutations are associated with atherosclerosis, hypertension, type 2 diabetes, cardiovascular disease, and obesity.
“Moreover, mtDNA mutations have been associated with the development of chronic human diseases, such as atherosclerosis, hypertension, T2DM, cardiovascular disease and obesity175–178.”
From Mitochondrial and metabolic dysfunction in ageing and age-related diseases (2022) · cites this paper as [175]
Cites
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277 · see citing works
Cambien, F., Poirier, O., Lecerf, L., Evans, A., Cambou, J., Arveiler, D., Luc, G., Bard, J., Bara, L., Ricard, S., et al. (1992) · Nature · doi:10.1038/359641a0 · Cited by 1,908 · see citing works
van den Ouweland, J. M. W., Lemkes, H. H. P. J., Ruitenbeek, W., Sandkuijl, L. A., de Vijlder, M. F., Struyvenberg, P. A. A., van de Kamp, J. J. P., & Maassen, J. A. (1992) · Nature Genetics · doi:10.1038/ng0892-368 · Cited by 1,127 · see citing works
Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age
Corral-Debrinski, M., Horton, T., Lott, M. T., Shoffner, J. M., Flint Beal, M., & Wallace, D. C. (1992) · Nature Genetics · doi:10.1038/ng1292-324 · Cited by 890 · see citing works
Oxidative damage to DNA in diabetes mellitus
Dandona, P., Thusu, K., Cook, S., Snyder, B., Makowski, J., Armstrong, D., & Nicotera, T. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90013-6 · Cited by 788 · see citing works
A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA.
Kadowaki, T., Kadowaki, H., Mori, Y., Tobe, K., Sakuta, R., Suzuki, Y., Tanabe, Y., Sakura, H., Awata, T., Goto, Y.-I., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404073301403 · Cited by 551 · see citing works
Self-citationKobayashi, Y., Momoi, M. Y., Tominaga, K., Momoi, T., Nihei, K., Yanagisawa, M., Kagawa, Y., & Ohta, S. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80860-5 · Cited by 363 · see citing works
Self-citationPolymorphism of the NADH/NADPH Oxidase p22 phox Gene in Patients With Coronary Artery Disease
Inoue, N., Kawashima, S., Kanazawa, K., Yamada, S., Akita, H., & Yokoyama, M. (1998) · Circulation · doi:10.1161/01.cir.97.2.135 · Cited by 238 · see citing works
Viedt, C., Soto, U., Krieger‐Brauer, H. I., Fei, J., Elsing, C., Kübler, W., & Kreuzer, J. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.4.940 · Cited by 216 · see citing works
Oxidative DNA damage in diabetes mellitus: its association with diabetic complications
Hinokio, Y., Suzuki, S., Hirai, M., Chiba, M., Hirai, A. M., & Toyota, T. (1999) · Diabetologia · doi:10.1007/s001250051258 · Cited by 209 · see citing works
Mechanism of somatic mitochondrial DNA mutations associated with age and diseases
Ozawa, T. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(95)00026-z · Cited by 152 · see citing works
Oxidative damage to mitochondrial DNA and its relationship to diabetic complications
Suzuki, S., Hinokio, Y., Komatu, K., Ohtomo, M., Onoda, M., Hirai, S., Hirai, M., Hirai, A. M., Chiba, M., Kasuga, S., et al. (1999) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00046-7 · Cited by 135 · see citing works
Human aging is associated with stochastic somatic mutations of mitochondrial DNA
Kadenbach, B., Münscher, C., Frank, V., Müller‐Höcker, J., & Napiwotzki, J. (1995) · Mutation Research/DNAging · doi:10.1016/0921-8734(95)00021-w · Cited by 125 · see citing works
Hayashi, J., Ohta, S., Kagawa, Y., Kondo, H., Kaneda, H., Yonekawa, H., Takai, D., & Miyabayashi, S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37457-4 · Cited by 118 · see citing works
Self-citationHuman Aging is Associated with Various Point Mutations in tRNA Genes of Mitochondrial DNA
Münscher, C., Müller‐Höcker, J., & Kadenbach, B. (1993) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1993.374.7-12.1099 · Cited by 96 · see citing works
Satō, K., Nishizawà, Y., Hosoi, M., Kawagishi, T., Maekawa, K., Shoji, T., Okuno, Y., & Morii, H. (1997) · Diabetes · doi:10.2337/diab.46.4.682 · Cited by 89 · see citing works
Aging and high concentrations of glucose potentiate injury to mitochondrial DNA
Fukagawa, N. K., Li, M., Liang, P., Russell, J. C., Sobel, B. E., & Absher, P. M. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00189-6 · Cited by 60 · see citing works
Liang, P., HUGHES, V. A., & Fukagawa, N. K. (1997) · Diabetes · doi:10.2337/diab.46.5.920 · Cited by 58 · see citing works
Nomiyama, T., Tanaka, Y., Hattori, N., Nishimaki, K., Nagasaka, K., Kawamori, R., & Ohta, S. (2002) · Diabetologia · doi:10.1007/s00125-002-0893-7 · Cited by 55 · see citing works
Self-citationRossi, G. P., Sacchetto, A., Rizzoni, D., Bova, S., Porteri, E., Mazzocchi, G., Belloni, A. S., Bahçelioğlu, M., Nussdorfer, G. G., & Pessina, A. C. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.4.949 · Cited by 53 · see citing works
Asymptomatic hyperglycaemia and early atherosclerotic changes
Kawamori, R. (1998) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(98)00041-2 · Cited by 43 · see citing works
Self-citationPiao, L., Tanaka, Y., Nomiyama, T., Nakajima, K., Ogihara, T., Miwa, S., Urabe, T., Watada, H., & Kawamori, R. (2002) · Current Therapeutic Research · doi:10.1016/s0011-393x(02)80089-3 · Cited by 6 · see citing works
Self-citation
Flagged first, then by citations
2 of the 24 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Mitochondrial and metabolic dysfunction in ageing and age-related diseases
Amorim, J. A., Coppotelli, G., Rolo, A. P., Palmeira, C. M., Ross, J. M., & Sinclair, D. A. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00626-7 · Cited by 990 · see citing works
Mitochondria, endothelial cell function, and vascular diseases
Tang, X., Luo, Y., Chen, H., & Liu, D. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00175 · Cited by 345 · see citing works
Murphy, R., Turnbull, D. M., Walker, M., & Hattersley, A. T. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02359.x · Cited by 290 · see citing works
Genetic, pathogenetic, and phenotypic implications of the mitochondrial A3243G tRNALeu(UUR) mutation
Finsterer, J. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00836.x · Cited by 125 · see citing works
Fetterman, J. L., Holbrook, M., Westbrook, D. G., Brown, J. A., Feeley, K. P., Bretón‐Romero, R., Linder, E. A., Berk, B. D., Weisbrod, R. M., Widlansky, M. E., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0372-y · Cited by 106 · see citing works
Genetic determinants of carotid ultrasound traits
Pollex, R. L., & Hegele, R. A. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0075-z · Cited by 55 · see citing works
Etiology of type 2 diabetes and Alzheimer’s disease: Exploring the mitochondria
Silzer, T. K., & Phillips, N. R. (2018) · Mitochondrion · doi:10.1016/j.mito.2018.04.004 · Cited by 53 · see citing works
Sobenin, I. A., Mitrofanov, K. Y., Викторович, Ж. А., Sazonova, M. A., Postnov, A. Y., Ревин, В. В., Bobryshev, Y. V., & Orekhov, A. N. (2014) · BioMed Research International · doi:10.1155/2014/292017 · Cited by 52 · see citing works
The alterations of mitochondrial DNA in coronary heart disease
Hu, H., Lin, Y., Xu, X., Lin, S., Chen, X., & Wang, S. (2020) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2020.104412 · Cited by 51 · see citing works
Dipeptidyl peptidase-4 inhibitor linagliptin attenuates neointima formation after vascular injury
Terawaki, Y., Nomiyama, T., Kawanami, T., Hamaguchi, Y., Takahashi, H., Tanaka, T., Murase, K., Nagaishi, R., Tanabe, M., & Yanase, T. (2014) · Cardiovascular Diabetology · doi:10.1186/preaccept-9752811371415510 · Cited by 48 · see citing works
Self-citationRole of somatic mutations in vascular disease formation
Weakley, S. M., Jiang, J. H., Kougias, P., Lin, P. H., Yao, Q. C., Brunicardi, F. C., Gibbs, R. A., & Chen, C. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.1 · Cited by 42 · see citing works
Volobueva, A. S., Grechko, A. V., Yet, S., Sobenin, I. A., & Orekhov, A. N. (2019) · Biomolecules · doi:10.3390/biom9080377 · Cited by 38 · see citing works
Orekhov, A. N., Nikiforov, N. G., Ivanova, E. A., & Sobenin, I. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9040978 · Cited by 37 · see citing works
Medikayala, S., Piteo, B., Zhao, X., & Edwards, J. G. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00248.2010 · Cited by 36 · see citing works
Mitochondrial Aging: Focus on Mitochondrial DNA Damage in Atherosclerosis - A Mini-Review
Sobenin, I. A., Викторович, Ж. А., Sinyov, V. V., Bobryshev, Y. V., & Orekhov, A. N. (2014) · Gerontology · doi:10.1159/000368923 · Cited by 33 · see citing works
Singh, R., Ellard, S., Hattersley, A. T., & Harries, L. W. (2006) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2006.050067 · Cited by 30 · see citing works
Chistiakov, D. A. (2012) · World Journal of Cardiology · doi:10.4330/wjc.v4.i5.148 · Cited by 25 · see citing works
Stability of mitochondrial DNA against reactive oxygen species (ROS) generated in diabetes
Savu, O., Sunkari, V. G., Botusan, I. R., Grünler, J., Nikoshkov, A., & Catrina, S. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1203 · Cited by 25 · see citing works
Is atherosclerosis a mitochondrial disorder?
Finsterer (2007) · VASA · doi:10.1024/0301-1526.36.4.229 · Cited by 24 · see citing works
Sazonova, M. A., Chicheva, M. M., Викторович, Ж. А., Sobenin, I. A., Bobryshev, Y. V., & Orekhov, A. N. (2015) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2015.04.003 · Cited by 21 · see citing works
Hicks, S. D., Labinskyy, N., Piteo, B., Laurent, D., Mathew, J., Gupte, S. A., & Edwards, J. G. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00567.2012 · Cited by 20 · see citing works
Orekhov, A. N., Владимировна, Г. Е., Sukhorukov, V. N., Poznyak, A. V., & Nikiforov, N. G. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666201012164330 · Cited by 9 · see citing works
Pinker, S. A., & Ullman, M. T. (2002) · Cited by 8 · see citing works
Purnamasari, D., Abdaly, M. S., Azizi, M. S., Wijaya, I. P., & Nugroho, P. (2019) · Vascular Health and Risk Management · doi:10.2147/vhrm.s195776 · Cited by 6 · see citing works
Naveed, A. K., Wahid, M., & Naveed, A. (2009) · International Journal of Diabetes Mellitus · doi:10.1016/j.ijdm.2009.03.012 · Cited by 5 · see citing works
Sangatsuda, Y., Nakamura, M., Tomiyasu, A., Deguchi, A., Toyota, Y., Goto, Y., Nishino, I., Ueno, S., & Sano, A. (2012) · Mitochondrion · doi:10.1016/j.mito.2012.10.002 · Cited by 5 · see citing works
Mutations of mitochondrial genome and atherosclerosis: Possible mechanistic relationship
Sobenin, I. A., Bobryshev, Y. V., Romanenko, E. B., & Orekhov, A. N. (2014)
- Authors
- NOMIYAMA, T., TANAKA, Y., PIAO, L., HATTORI, N., UCHINO, H., WATADA, H., KAWAMORI, R., & OHTA, S.
- Affiliations
- Juntendo University (JP)
- Yanbian University (CN)
- Nippon Medical School (JP)
- Corresponding author
- TANAKA, YASUSHI
- ORCID
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2004-04
- Volume
- 1011
- Issue
- 1
- Pages
- 193-204
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W2031452330
- Cited by
- 27
- References
- 24
- Citations by year
- 2022: 1 · 2020: 3 · 2019: 2 · 2018: 1 · 2016: 1 · 2015: 1 · 2014: 5 · 2013: 1 · 2012: 2
- FWCI
- 0.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of the New York Academy of Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
- Keywords
- mitochondrial DNA, somatic mutations, A3243G mutation, type 2 diabetes, atherosclerosis, oxidative stress, diabetes duration, carotid intima-media thickness, ACE I/D polymorphism
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Arteriosclerosis, Child, Child, Preschool, Diabetes Mellitus, DNA, Mitochondrial, Female, Genotype, Humans, Infant, Infant, Newborn, Male, Middle Aged, Point Mutation, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review